Affiliation:
1. Department of Bacteriology and Immunology, Haartman Institute, University of Helsinki, and Helsinki University Central Hospital Laboratory Diagnostics
2. Department of Food and Environmental Hygiene, University of Helsinki, Helsinki, Finland
Abstract
ABSTRACT
The in vitro susceptibilities of 678
Campylobacter jejuni
and
Campylobacter coli
strains isolated from stool samples of the same number of Finnish subjects were studied. A total of 523 patients, representing inhabitants from throughout Finland, had not traveled abroad within the 2 weeks prior to becoming ill, whereas 155 persons had presumably acquired their infections abroad. The antimicrobial agents studied were erythromycin, ciprofloxacin, levofloxacin, trovafloxacin, and moxifloxacin. The MICs of these antimicrobial agents were determined by the agar dilution method. The growth of all domestic isolates was inhibited by erythromycin at concentrations of 4 μg/ml, and for these isolates the fluoroquinolone MICs at which 90% of isolates are inhibited (MIC
90
s) ranged from 0.06 to 0.5 μg/ml. For the foreign isolates, the erythromycin MIC
90
was still low (4 μg/ml), but their susceptibilities to fluoroquinolones were clearly reduced (MIC
90
s, 8 to 64 μg/ml). Of the four different fluoroquinolones studied, ciprofloxacin was the least active (MIC
90
, 64 μg/ml).
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference27 articles.
1. Adachi, J. A., L. Ostrosky-Zeichner, H. L. DuPont, and C. D. Ericsson. 2000. Empirical antimicrobial therapy for traveler's diarrhea. Clin. Infect. Dis.31:1079-1083.
2. Andrews, J. M., J. P. Ashby, G. M. Jevons, and R. Wise. 1999. Tentative minimum inhibitory concentration and zone diameter breakpoints for moxifloxacin using BSAC criteria. J. Antimicrob. Chemother.44:819-822.
3. Endtz, H. P., G. J. Ruijs, B. van Klingeren, W. H. Jansen, T. van der Reyden, and R. P. Mouton. 1991. Quinolone resistance in campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine. J. Antimicrob. Chemother.27:199-208.
4. Friedman J. J. Neimann H. C. Wegener and R. V. Tauxe. 2000. Epidemiology of Campylobacter jejuni infections in the United States and other industrialized nations p. 121-138. In I. Nachamkin and M. J. Blaser (ed.) Campylobacter 2nd ed. American Society for Microbiology Washington D.C.
5. Fuchs, P. C., A. L. Barry, and S. D. Brown. 1999. In vitro activity of trovafloxacin against ciprofloxacin-susceptible and -resistant clinical bacterial isolates and assessment of the trovafloxacin disk test. Diagn. Microbiol. Infect. Dis.33:33-38.
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献